SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-181939
Filing Date
2021-06-04
Accepted
2021-06-04 06:08:01
Documents
13
Period of Report
2021-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d159613d8k.htm   iXBRL 8-K 33158
5 GRAPHIC g159613g0604012559692.jpg GRAPHIC 2384
  Complete submission text file 0001193125-21-181939.txt   159958

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20210603.xsd EX-101.SCH 3092
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20210603_lab.xml EX-101.LAB 17372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20210603_pre.xml EX-101.PRE 10967
6 EXTRACTED XBRL INSTANCE DOCUMENT d159613d8k_htm.xml XML 3333
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 21994796
SIC: 8071 Services-Medical Laboratories